Epirubicin
- 1 January 1993
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 45 (Supplement), 20-30
- https://doi.org/10.2165/00003495-199300452-00005
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Hematopoietic colony-stimulating factors. Uses in combination with standard chemotherapeutic regimens and in support of dose intensification.1992
- Weekly Epirubicin Versus Doxorubicin as Second Line Therapy in Advanced Breast Cancer A Randomized Clinical TrialAmerican Journal of Clinical Oncology, 1991
- High-Dose Epirubicin in Combination with Cyclophosphamide (HD-EC) in Advanced Breast Cancer: Final Results of a Dose Finding Study and Phase II TrialOncology Research and Treatment, 1990
- Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in cultureBiochemical Pharmacology, 1989
- Epirubicin and doxorubicin comparative metabolism and pharmacokineticsCancer Chemotherapy and Pharmacology, 1988
- A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.Journal of Clinical Oncology, 1987
- Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patientsCancer Chemotherapy and Pharmacology, 1986
- Experimental systemic toxicology of 4′-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agentToxicology and Applied Pharmacology, 1985
- Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1984
- CROSSOVER STUDY OF PHARMACOKINETICS AND HEMATOLOGICAL TOXICITY OF 4'-EPI-DOXORUBICIN AND DOXORUBICIN IN CANCER-PATIENTS1984